Accéder au contenu
Merck
AccueilWebinarsRisk considerations for the presence of pyrogens and the need for the MAT test in pharmaceutical processing

Risk considerations for the presence of pyrogens and the need for the MAT test in pharmaceutical processing

Webinar

Pyrogens can cause severe reactions such as fever, rash, headache or toxic shock to the recipient. To minimize the risks from these sources, FDA and EMA recommend good control of the microbiological and endotoxin levels of contamination in the potential source. In this lecture, you will learn how to test for pyrogen (including non-endotoxin pyrogens) in your pharmaceutical samples, what are the existing methods in order to have a controlled process.

Speakers

Tim Sandle

University of College London & University of Manchester

Head of Microbiology at BPL and visiting tutor

Webinar Information

Microbiological testing

  • Pyrogen testing
  • Duration:24 min

  • Language:English

  • Presented:


Connectez-vous pour continuer

Pour continuer à lire, veuillez vous connecter à votre compte ou en créer un.

Vous n'avez pas de compte ?